- Aim is to develop gamma delta (?d) T-cell receptor (TCR)-based immunotherapies for solid tumors - Ph1/2 update on lead product GDT002 as well as nomination of second pipeline program
Gadeta announces significant progress in advancing pipeline and TEG platform development streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.